Skip to main content

Ethic Inc.

SEC CIK
0001780570
Latest filing
Jul 29, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Ethic Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
16,069
Value
$10.0M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Ethic Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,069$10.0M0.1%+1,052+7.0%AddedHolders
Q1 202615,017$11.6M0.2%−926−5.8%ReducedHolders
Q4 202515,943$12.3M0.2%−550−3.3%ReducedHolders
Q3 202516,493$9.27M0.2%−354−2.1%ReducedHolders
Q2 202516,847$8.78M0.2%+9,766+137.9%AddedHolders
Q1 20257,081$4.37M0.1%−3,587−33.6%ReducedHolders
Q4 202410,668$7.60M0.2%+4,509+73.2%AddedHolders
Q3 20246,159$5.93M0.1%−284−4.4%ReducedHolders
Q2 20246,443$6.77M0.2%+284+4.6%AddedHolders
Q1 20246,159$5.93M0.1%+602+10.8%AddedHolders
Q4 20235,557$4.88M0.1%−261−4.5%ReducedHolders
Q3 20235,818$4.79M0.2%+177+3.1%AddedHolders
Q2 20235,641$4.05M0.2%+60+1.1%AddedHolders
Q1 20235,581$4.59M0.2%+2,271+68.6%AddedHolders
Q4 20223,310$2.39M0.1%+876+36.0%AddedHolders
Q3 20222,434$1.68M0.1%−37−1.5%ReducedHolders
Q2 20222,471$1.46M0.1%+542+28.1%AddedHolders
Q1 20221,929$1.35M0.1%+404+26.5%AddedHolders
Q4 20211,525$963.0K0.1%+132+9.5%AddedHolders
Q3 20211,393$843.0K0.1%+355+34.2%AddedHolders
Q2 20211,038$580.0K0.1%+290+38.8%AddedHolders
Q1 2021748$354.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.